PHARMINE

1
PHARMINE

• Kick-off meeting
• Brussels 4/2/2009
• WP7 the PHARMINE databank
• J. Atkinson, PCN, France.

2
PHARMINE WP7Why?
One amongst several emails to the president
of the EAFP From Nese Kirimer
ltnkirimer_at_gmail.comgtDate 2009/1/12Dear Dr.
Atkinson   Many thanks for your time and the
valuable information if you kindly allow me I
would like to ask for clarification on the
following point. Can you give me an example on
the curriculum of a faculty of pharmacy in the
first 3 years and then for the following two
years?   Best regards. NK
3
PHARMINE WP7

• P. Bourlioux TEMPUS project for survey of EU
  pharmacy education (1995-7)
• Creation of the EAFP
• Recommendations to the EU

4
PHARMINE WP7

• Chapter headings
• Aim Partners
• Methodology
• Timing, deadlines
• Results
• Interpretation
• Dissemination

5
PHARMINE WP7
1. Aim partners
6
PHARMINE WP7

• Aim to produce (deadline 12/2009) and maintain
  the PHARMINE databank on EU HEIs in pharmacy
• Partners
• Leader PCN, Nancy (P9)
• Core P2/P4/P1/P3
• Associates
• Tartu
• New member states
• Others list of database contacts to be filled
  in.
• Interactions with other WPs

7
PHARMINE WP7
2. Methodology. Data to be collected
8
PHARMINE WP7
2. Data to be collected on the country its
health system
9
PHARMINE WP7

• Member state
• Population, area
• Life expectancy, GNP
• Health insurance policy schemes
• Numbers and functions of
• community pharmacies /pharmacists
• hospital pharmacies/pharmacists
• industrial pharmacists
• Professional bodies role in
• registration of pharmacists
• creation of pharmacies
• ethical and other conduct
• QA/validation of HEI courses

10
PHARMINE WP7
2. Data to be collected on HEIs, organisation of
pharmacy education and training
11
PHARMINE WP7

• Higher education institutions (HEIs)
• Number of HEIs for ET in pharmacy
• Public or private
• Numbers of students, teaching and technical staff
  (native and foreign (non-MS and non-EU) )
• Entry requirements typical school-leaving offer,
  numerus clausus
• Number of places/ number of applicants
• Is the HEI surveyed typical of all the HEIs of
  the country? If not how do HEIs vary?

12
PHARMINE WP7
2. Data to be collected on pharmacy ET
13
PHARMINE WP7

• Evaluation of education and training
• Course length (years, semesters)
• Entrance requirements
• Level B1
• Advanced entry
• M1
• Intermediate levels
• Changes (recent past, future)
• Special features of HEI and/or MS
• Evaluation by subject area or competences?
• Programmes do not give hours or ECTSs for
  competences
• EAFP TEMPUS project (Bourlioux, 1995/7) used
  subject areas
• Avoid pre-emption of WPs 3-5 (put forward
  competences means to attain objectives based on
  what, when how to teach)

14
PHARMINE WP7

• Methodology of analysis of course
• Analysis of courses based on 7 subject areas 
  approach
• Model/paradigm French pharmacy E T programme
• J. Atkinson has 24 years experience of it
• Relatively stable over past 10 years
• Produce numerical data (as far as possible,
  possibility of verbal development) for
• statistical analysis to avoid subjective
  appreciation leading to proneness
• graphical presentation for ease of understanding

15
PHARMINE WP7

• Methodology of analysis of course
• Classsification by 4 parameters
• 7 subject areas (chemistry)
• 4 types of learning (lectures)
• Traineeship (C, H, I)
• Electives (permitting a choice)
• Choice of course amongst a group of obligatory
  courses
• Optional courses (choice is Y/N and has no effect
  on obtention of diploma)

16
PHARMINE WP7

• Subject area I Chemical sciences CHEMSCI
• General, organic inorganic chemistry
• Analytical chemistry
• Pharmaceutical chemistry /pharmacopeial analysis
• Medicinal physicochemistry SAR

17
PHARMINE WP7

• Subject area II Physical and Mathematical
  Sciences
• PHYSMATH
• Physics
• Mathematics, pharmaceutical calculations
• Information technology (IT)
• Statistics
• Experimental design analysis

18
PHARMINE WP7

• Subject area III Biological Sciences BIOLSCI
• Foundation biology
• Cell biology
• Botany
• Zoology
• Biochemistry
• Microbiology

19
PHARMINE WP7

• Subject area IV Pharmaceutical Technology
• PHARMTECH
• Galenic formulation
• Drug disposition and metabolism (ADME)
• Novel drug delivery systems
• Drug design
• Pharmaceutical RD

20
PHARMINE WP7

• Subject area V Medicinal sciences
• MEDISCI
• Human anatomy physiology
• Medical terminology
• Pharmacology, therapeutics, toxicology
• Pathology, histology
• Nutrition, non-pharmacological treatment
• Hematology
• Immunology
• Parasitology
• Hygiene
• Emergency therapy
• Clinical chemistry, bioanalysis (of body fluids)
• Radiochemistry

21
PHARMINE WP7

• Subject area VI Law and social sciences
• LAWSOC
• Legislation, law relating to pharmacy
• Social sciences
• Forensic science
• Professional ethics
• Philosophy
• Economics
• Public health/health promotion
• History of pharmacy

22
PHARMINE WP7

• Subject area VII Generic competences
• GENERIC
• General knowledge
• Academic literacy
• Languages
• First aid
• Communication
• Management
• Practical skills

23
PHARMINE WP7
2. Data to be collected on impact of the 6
principles of Bologna on pharmacy ET
24
PHARMINE WP7Six principles of Bologna

• easily readable and comparable degrees
• Diploma Supplement
• two main cycles
• 3 year undergraduate (B) and graduate (M D)
• degree awarded after first cycle relevant to the
  European labour market
• system of credits (ECTS )
• student mobility
• can be acquired in non-higher education contexts
• include lifelong learning (LLL)
• mobility
• identify remove obstacles
• European co-operation in quality assurance
• comparable criteria and methodologies

25
PHARMINE WP7Adherence to 6 principles of Bologna

• For each of the 6 Bologna principles
• Is this principle adapted at the HEI? (Y/N)
• In what way? (description)
• Are there multilateral agreements on principles
  i.e. are ECTS obtained at a second HEI accepted
  as such by the HEI of origin? (Y/N with
  description)

26
PHARMINE WP7

• 2.
• Data to be collected on impact of 3 main elements
  of directive 2005/36/EC on ET
• Course length
• Course content
• Traineeship

27
PHARMINE WP7
3. Timing, deadlines
28
PHARMINE WP7

• Timetable
• Kick-off 4/2/2009 (officially 1/10/2008)
• Phase I
• Deadline 1/5/2009 (report DDISS1 ?)
• Production V1 of questionnaire
• Validation (FR, DE, UK)
• Production V2
• Phase II
• Deadline 1/1/2010
• Production of databank
• Presentation to WPs 3, 4 5
• Phase III
• Deadline end of project (reports DDISS2 DDEV1)
• Dissemination (paper electronic)

29
PHARMINE WP7
4. Results, statistical treatment
interpretation
30
PHARMINE WP7
Example first 4 years of curriculum in France
(common to all students)
31
PHARMINE WP7

• France special features
• Integrated teaching , e.g. cardiovascular system
• Human anatomy, histology, physiology
• Pathology, elements of diagnosis
• Pharmacology, therapeutics
• Health-care issues
• Combined hospital internship with research career
• Double degree, pharmacy plus
• Chemical engineering
• Agricultural science

32
PHARMINE WP7

• Interpretation
• Impact on
• WP7 (were aims achieved?)
• WPs 3, 4 5 (one element in elaboration of
  models for ET)

33
PHARMINE WP7
WPs 3,4 5 In consultation with various
organisations
Databank WP 7

Recommendations of competences required for
pharmacist (C, H, I)
Suggestions for ways to obtain above competences
Recommendations to EU and MSs
34
PHARMINE WP7

• Dissemination
• HEI databank to be used for
• Interaction between HEIs, MSs
• Educational research
• EU pharmacy ET model for
• EU new directive
• MS and outside world

35
PHARMINE WP7
Follow-up project Quote from the EACEA
evaluation report on PHARMINE (6/8/2008) It
would be useful to implement the newly developed
curriculum as a pilot projectin order to be able
to assess it efficiency and effectiveness.